Drugs like Ozempic have transformed how we treat obesity, but a review of almost 40 studies shows it doesn't take long for ...

Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

Arrowhead Pharmaceuticals disclosed that its gene-silencing candidates helped people with obesity lose fat, very early ...

Bariatric surgery far outperformed GLP-1 weight loss drugs in a new real-world comparison of more than 50,000 patients. Two ...

Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...

Nimbus Therapeutics said on Tuesday it has entered into a multi-year research and licensing agreement with Eli Lilly to develop artificial intelligence-driven new oral treatments for obesity and other ...

Arrowhead’s experimental therapy helped patients on Lilly’s Zepbound lose more weight and visceral fat—but cost and ...

Arrowhead Pharmaceuticals said Tuesday that its gene-silencing candidates helped people with obesity lose fat.

Arrowhead Pharma (ARWR) stock jumps as obesity drug ARO-INHBE doubles weight loss with Eli Lilly’s (LLY) GLP-1 therapy, ...

Headache wasn’t reported as a side effect in Zepbound’s studies. But, it may be a symptom of some of Zepbound’s side effects. More common side effects of Zepbound are digestive side effects, such as ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Researchers from Macquarie University have published the world's first ever consensus-based recommendations on exercise as part of the management of lower limb lymphedema, a condition affecting ...